清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

What is the optimal duration of neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer (NSCLC)?: a real-world study

化学免疫疗法 医学 新辅助治疗 内科学 优势比 肿瘤科 逻辑回归 阶段(地层学) 比例危险模型 置信区间 肺癌 多元分析 腺癌 癌症 外科 免疫疗法 古生物学 乳腺癌 生物
作者
Zhoujunyi Tian,Haoshuai Yang,Jin Zhang,Deruo Liu,Chaoyang Liang,Zhenrong Zhang
出处
期刊:European Journal of Cardio-Thoracic Surgery [Oxford University Press]
卷期号:67 (7) 被引量:1
标识
DOI:10.1093/ejcts/ezaf218
摘要

OBJECTIVES: The optimal duration of neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer remains unknown. This study aimed to assess whether the number of cycles of neoadjuvant therapy affects oncologic efficacy and surgical safety in a real-world setting. METHODS: Patients with resectable non-small cell lung cancer who received neoadjuvant chemoimmunotherapy and subsequent surgery were included. Patients were divided into 2 groups: ≤2 or >2 cycles. Oncology outcomes such as pathological complete response (pCR) and surgical outcomes were compared. Binary logistic regression analyses were conducted to identify independent factors for pCR. Kaplan-Meier analysis was used to compare long-term survival between groups. Cox regression analyses were conducted to identify independent predictors of recurrence. RESULTS: A total of 140 patients with clinical stage IB-IIIB disease were included; 68 received ≤2 cycles and 72 received >2 cycles of neoadjuvant chemoimmunotherapy. No significant differences between groups were observed in pCR rates, surgery difficulty, and postoperative complications. Multivariate binary logistic regression analysis indicated that adenocarcinoma [odds ratio 0.14, 95% confidence interval 0.04-0.50, P = .003] and clinical T3 stage (odds ratio 0.18, 95% confidence interval 0.05-0.72, P = .015) were unfavourable factors for pCR. Kaplan-Meier survival analysis revealed no significant difference in recurrence-free survival or overall survival between groups. Multivariate Cox regression analysis revealed that the number of neoadjuvant cycles was not a predictor of recurrence (hazard ratio 0.87, 95% confidence interval 0.31-2.44, P = .8). CONCLUSIONS: Compared with 3 or more cycles, 2 cycles of neoadjuvant chemoimmunotherapy might achieve similar perioperative outcomes and long-term survival in selected patients. Prospective studies and extended follow-up are needed to verify the conclusions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
vitamin完成签到 ,获得积分0
7秒前
大胆的鲂完成签到,获得积分20
12秒前
16秒前
林子鸿完成签到 ,获得积分10
27秒前
29秒前
wht发布了新的文献求助10
33秒前
chengzdao完成签到,获得积分10
37秒前
呆萌如容完成签到,获得积分10
1分钟前
尼尼应助科研通管家采纳,获得10
1分钟前
sanmu完成签到,获得积分10
1分钟前
1分钟前
sanmu发布了新的文献求助10
1分钟前
小一发布了新的文献求助10
1分钟前
无花果应助sanmu采纳,获得10
1分钟前
abc完成签到 ,获得积分10
1分钟前
默默无闻完成签到 ,获得积分10
2分钟前
楚科研完成签到 ,获得积分10
2分钟前
大魔王发布了新的文献求助10
2分钟前
123完成签到 ,获得积分10
2分钟前
3分钟前
Copyright应助科研通管家采纳,获得10
3分钟前
Kao应助科研通管家采纳,获得10
3分钟前
Kao应助科研通管家采纳,获得10
3分钟前
3分钟前
共享精神应助Winnie采纳,获得10
3分钟前
3分钟前
Winnie发布了新的文献求助10
3分钟前
涛涛完成签到,获得积分10
3分钟前
zhang完成签到,获得积分10
4分钟前
Noob_saibot完成签到,获得积分10
4分钟前
4分钟前
大魔王完成签到,获得积分10
4分钟前
Kao应助科研通管家采纳,获得30
5分钟前
Kao应助科研通管家采纳,获得30
5分钟前
Kao应助科研通管家采纳,获得30
5分钟前
Kao应助科研通管家采纳,获得10
5分钟前
整齐的不评完成签到,获得积分10
5分钟前
美丽的沛菡完成签到,获得积分10
5分钟前
广州小肥羊完成签到 ,获得积分10
5分钟前
lenne完成签到,获得积分10
5分钟前
高分求助中
Principles of Economics, 11th Edition 10000
Prescott's Microbiology: 2026 Release ISE 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Cronologia da história de Macau 5000
Environmental Leverage in Times of Climate Crisis: Product Standards, Carbon Border Measures and Preferential Trade Agreements 1000
Interactions of Vowel Quality and Prosody in East Slavic 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7164098
求助须知:如何正确求助?哪些是违规求助? 8807055
关于积分的说明 18610479
捐赠科研通 6771989
什么是DOI,文献DOI怎么找? 3164725
关于科研通互助平台的介绍 2303164
邀请新用户注册赠送积分活动 2139350